GLOW Blend (GHK-Cu / BPC-157 / TB-500): Tracking a Multi-Peptide Stack

"GLOW" is a marketing label used by various research suppliers for a blend of GHK-Cu, BPC-157, and TB-500. The pitch is usually a combined effect on skin quality, recovery, and tissue repair. There is no clinical trial of this specific combination, no standard dose, and no regulatory approval for any of the three peptides as therapeutics. This post is about how to think about and track such a stack responsibly, not a recommendation to use one.

What's in the blend

• GHK-Cu: a copper-binding tripeptide with topical and injectable use claims around skin, hair, and wound healing
• BPC-157: a pentadecapeptide derived from a fragment of a gastric protein, studied in animal models for gut and tendon repair
• TB-500: a synthetic fragment of Thymosin Beta-4, studied for tissue repair and inflammation modulation

Each peptide on its own has limited human evidence. The blend has none in published trials.

The attribution problem

This is the central honest point: if you use a three-peptide blend and you notice a change — good or bad — you cannot tell which peptide caused it. You cannot tell whether two of them did nothing and one did the work. You cannot tell whether they interact synergistically, additively, or antagonistically. Standard pharmacology vocabulary doesn't apply because no one has measured.

That doesn't mean don't use a blend. It means be honest with yourself about what your data can and cannot tell you.

Typical protocol shape

Reported protocols vary widely. A common pattern:

• Frequency: daily SC injection during a 4-8 week course
• Dose: blend label dose varies by supplier; user reports cluster around totals that approximate standard per-peptide doses
• Site: many users rotate sites or inject near a target area, though systemic absorption likely dominates

There is no validated protocol. Pick a single supplier, document the label dose precisely, and stick to one protocol for the duration so your data is internally consistent.

What to track daily

• Injection site, dose, time
• Injection site reactions (GHK-Cu can sting; copper can leave faint blue tinting)
• Energy
• Sleep
• Joint pain at the target area (if any)
• Any GI changes (BPC-157 is often used for gut effects)
• Mood

What to track weekly

• Photos of skin (consistent lighting, same angles)
• Range of motion or pain scores at any injury site
• Recovery quality after training
• Resting heart rate
• Any new bruising or unusual bleeding

Bloodwork worth doing

• Baseline: CBC, CMP, lipid panel, hs-CRP, ferritin
• Week 8: repeat CBC, CMP, hs-CRP

There are no validated biomarkers for any of the three peptides individually, let alone the blend. Standard panels are about catching unexpected drift, not measuring efficacy.

Realistic expectations

The most consistently reported subjective effects are skin quality changes (often attributed to GHK-Cu), faster soft tissue recovery (often attributed to BPC-157 or TB-500), and reduced injury site pain. None of these are validated in controlled human trials of the blend. Placebo and natural healing trajectories are real confounds — a tendon injury improves over weeks regardless of intervention.

Common mistakes

• Attributing a specific effect to a specific peptide when you have no way to know
• Stacking the blend with another peptide protocol simultaneously and losing all ability to attribute anything
• Using a blend as your first peptide experience — you learn nothing transferable
• Skipping photos and relying on memory ("my skin looks better")
• Continuing past a planned endpoint because "something" seems to be working

How to track a blend responsibly

If you decide to use a blend, the most useful framing is:

• Treat the blend as a single intervention, not three
• Don't introduce other variables (new training program, new diet, other peptides) during the course
• Pre-commit to an endpoint and a small set of measurements
• Compare end-of-course measurements to baseline, not to peak feelings mid-course

A tracking template

In Peptide IA, a blend is best logged as a single named compound with the three component peptides listed in notes. Daily wellness sliders, weekly photos with a photo-log integration, and a single bloodwork comparison at baseline and end-of-course is the minimum useful protocol.

Bottom line

Proprietary multi-peptide blends are convenient and intellectually messy. They make attribution impossible by design. If you use one, be honest that what you're testing is "this blend at this dose for this duration," not the individual peptides. That framing keeps your conclusions honest and your data useful for your future self.

Peptide IA is an educational and self-tracking tool. Nothing in this post is medical advice. Doses mentioned reflect what is commonly reported in research literature — they are not recommendations. Always consult a qualified physician before starting, changing, or stopping any protocol.